Study Name: Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the El
9 locations found
- Community Research Initiative of New England
Location: Boston, Massachusetts 02215
- Dupont Circle Physician's Group
Location: Washington, District of Columbia 20009
- Capital Medical Associates, PC
Location: Washington, District of Columbia 20036
- Orlando Immunology Center
Location: Orlando, Florida 32803
- Gordon E. Crofoot, MD, PA
Location: Houston, Texas 77098
- Central Texas Clinical Research
Location: Austin, Texas 78705
- Kaiser Permanente Los Angeles
Location: Los Angeles, California 90027
- Peter J. Ruane, MD, Inc.
Location: Los Angeles, California 90036
- Anthony Mills MD, Inc
Location: Los Angeles, California 90069
|